Your browser doesn't support javascript.
loading
A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus.
Han, Lei; Shi, Chenchen; Zeng, Xian; Cen, Lifeng; Mei, Xiaobin; Fan, Jiajun; Ju, Dianwen; Zhu, Haiyan.
Afiliação
  • Han L; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
  • Shi C; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
  • Zeng X; Division of Spine, Department of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Cen L; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
  • Mei X; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
  • Fan J; Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, China.
  • Ju D; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
  • Zhu H; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
Front Immunol ; 12: 727941, 2021.
Article em En | MEDLINE | ID: mdl-34504501

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Proteínas Recombinantes de Fusão / Interleucinas / Infecções por Orthomyxoviridae / Interleucina-17 / Vírus da Influenza A Subtipo H1N1 / Lesão Pulmonar Aguda / Anticorpos Monoclonais Limite: Animals / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pneumonia Viral / Proteínas Recombinantes de Fusão / Interleucinas / Infecções por Orthomyxoviridae / Interleucina-17 / Vírus da Influenza A Subtipo H1N1 / Lesão Pulmonar Aguda / Anticorpos Monoclonais Limite: Animals / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça